Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir (Insulin Detemir) as Initiation Insulin Therapy by Levemir (Insulin Detemir) Administered 1 (Once) Daily as the Treatment of Type 2 Diabetes Mellitus.

Trial Profile

Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir (Insulin Detemir) as Initiation Insulin Therapy by Levemir (Insulin Detemir) Administered 1 (Once) Daily as the Treatment of Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms START
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Apr 2011 Actual patient numbers reported as 2188 by the Clinicaltrials.gov record
    • 19 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top